← Leaderboards
Andres Finzi
Univ Of Massachusetts Med Sch Worcester
$5,118,083
Attributed
$12,976,536
Total exposure
7
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.6M · FY2017–25$5M$3.8M$2.5M$1.3M$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,976,536 · 7
By mechanism
R01$12,387,533 · 5
P01$589,003 · 2
Top collaborators
- James B Munro7 shared
- David T Evans6 shared
- John C Kappes6 shared
- Marzena Elzbieta Pazgier6 shared
- Isabelle Rouiller5 shared
- Priti Kumar2 shared
- Joseph G Sodroski2 shared
Most similar at Univ Of Massachusetts Med Sch Worcester
Same institution · by research overlap
- Shan Lu$23,520,369
- James B Munro$8,916,187
- Phillip D Zamore$20,619,854
- Isabelle Rouiller$914,842
- Ann M Moormann$14,521,572
Others in their field
Other Emerging Leaders on “Cells”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$155,695,588
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
- Evan Z Macosko · Broad Institute, Inc.$33,096,828
- James Dale Berry · Brigham And Women'S Hospital$30,122,905
- Hanjoon Ryu$28,519,898
- Eric C Palm · Florida State University$26,502,247
Research focus
CellsAntibodiesViralMediatingEpitopesGlycoproteinsAntibody-Dependent Cell CytotoxicityVirusHiv Envelope Protein Gp120ResponseMolecular ConformationNovel StrategiesDesignHiv-1InfectionPredispositionStructureAcquired Immunodeficiency SyndromeImmune ResponseBaseVaccine TrialMolecularThailandAntigens
Grant awards (24)
Targeting the HIV-1 reservoir at cART initiation with CD4-mimetic interventions$1,363,055
R01 · FY2025 · AI
Exploring HIV-1 Env open conformations for therapeutic intervention$564,837
R01 · FY2025 · AI
Exploring HIV-1 Env open conformations for therapeutic intervention$174,960
R01 · FY2025 · AI
Targeting the HIV-1 reservoir at cART initiation with CD4-mimetic interventions$1,314,572
R01 · FY2024 · AI
A new strategy to eliminate HIV-1-infected cells by unlocking the Env trimer$699,744
R01 · FY2024 · AI
Characterizing HIV-1 Env conformations susceptible to attack by non-neutralizing antibodies$541,156
R01 · FY2024 · AI
Assessing ADCC and Fc-mediated Protection against HIV$767,088
R01 · FY2023 · AI
A new strategy to eliminate HIV-1-infected cells by unlocking the Env trimer$716,299
R01 · FY2023 · AI
Characterizing HIV-1 Env conformations susceptible to attack by non-neutralizing antibodies$538,456
R01 · FY2023 · AI
Assessing ADCC and Fc-mediated Protection against HIV$185,625
R01 · FY2023 · AI
Assessing ADCC and Fc-mediated Protection against HIV$767,578
R01 · FY2022 · AI
Characterizing HIV-1 Env conformations susceptible to attack by non-neutralizing antibodies$540,616
R01 · FY2022 · AI
Core B Cellular Core$99,395
P01 · FY2022 · AI · contact PI
Assessing ADCC and Fc-mediated Protection against HIV$764,967
R01 · FY2021 · AI
Characterizing HIV-1 Env conformations susceptible to attack by non-neutralizing antibodies$536,296
R01 · FY2021 · AI
Core B Cellular Core$99,646
P01 · FY2021 · AI · contact PI
Assessing ADCC and Fc-mediated Protection against HIV$656,716
R01 · FY2020 · AI
Characterizing HIV-1 Env conformations susceptible to attack by non-neutralizing antibodies$588,001
R01 · FY2020 · AI
Core B Cellular Core$99,890
P01 · FY2020 · AI · contact PI
Assessing ADCC and Fc-mediated Protection against HIV$684,196
R01 · FY2019 · AI
Core B Cellular Core$100,220
P01 · FY2019 · AI · contact PI
Unlocking Env: A New Strategy for a Functional Cure Through Antibody-Dependent Cell-Mediated Cytotoxicity$484,873
R01 · FY2018 · AI
Core B Cellular Core$189,852
P01 · FY2018 · GM · contact PI
Unlocking Env: A New Strategy for a Functional Cure Through Antibody-Dependent Cell-Mediated Cytotoxicity$498,498
R01 · FY2017 · AI